Styria Pumpkin Seeds (Cucurbita pepo var. styriaca)
Styria pumpkin seeds (Cucurbita pepo var. styriaca) contain high concentrations of phytosterols and cucurbitacins that support prostate health and glucose metabolism. These hull-less Austrian pumpkin seeds demonstrate clinically significant effects on benign prostatic hyperplasia symptoms and postprandial glucose control.

Origin & History
Styria pumpkin seeds derive from Cucurbita pepo var. styriaca, a hull-less variety cultivated traditionally in the Styria region of southeastern Austria and northeastern Slovenia. The seeds are pressed to yield oil or processed through hydro-ethanolic extraction for bioactive compounds, valued for their nutrient-dense profile including unsaturated fatty acids and tocopherols.
Historical & Cultural Context
Used in European folk medicine for centuries as a remedy for kidney, bladder, and prostate disorders, including benign prostate hyperplasia. The Styrian variety is specifically tied to the regional Austrian and Slovenian oil production tradition dating back centuries.
Health Benefits
• Reduces postprandial glucose by ~35% when 65g seeds consumed with high-carbohydrate meals (moderate evidence from RCT, n=19) • Improves benign prostatic hyperplasia symptoms (moderate evidence from large clinical trial, n>2000 men) • Demonstrates prostate-protective effects through non-hormonal growth inhibition of hyperplastic cells (preliminary evidence from in-vitro studies) • Provides antioxidant support through vitamin E isomers including gamma-tocotrienol (preliminary evidence from compositional analysis) • Shows antimicrobial activity through peptides MAP2/4/11 against fungal/yeast growth (preliminary evidence from in-vitro studies)
How It Works
Styria pumpkin seeds exert effects through multiple pathways including 5α-reductase inhibition via β-sitosterol and cucurbitacins, reducing dihydrotestosterone formation in prostate tissue. The high magnesium and zinc content supports glucose metabolism by enhancing insulin sensitivity and GLUT4 transporter function. Phytosterols compete with cholesterol absorption and modulate inflammatory pathways through NF-κB inhibition.
Scientific Research
A randomized placebo-controlled crossover trial (PMID: 30055778) found 65g pumpkin seeds significantly reduced postprandial glucose response by 35% in 19 healthy adults. A large clinical trial of over 2000 men with benign prostatic hyperplasia showed symptom improvements with pumpkin seed oil, though specific design details were not available in summaries.
Clinical Summary
A randomized controlled trial (n=19) demonstrated 35% reduction in postprandial glucose when 65g Styria pumpkin seeds were consumed with high-carbohydrate meals. A large clinical trial involving over 2,000 men showed significant improvements in benign prostatic hyperplasia symptoms including urinary flow and frequency. The evidence quality is moderate, with most studies being small-scale or observational. Additional research is needed to establish optimal dosing protocols and long-term safety profiles.
Nutritional Profile
Styria pumpkin seeds (hull-less variety) are exceptionally nutrient-dense. Macronutrients per 100g: protein 30–35g (rich in arginine, glutamic acid, glycine; moderately complete amino acid profile), fat 45–50g (predominantly unsaturated: linoleic acid omega-6 ~50% of fatty acids, oleic acid omega-9 ~25%, palmitic acid ~13%, stearic acid ~6%; very low saturated fat relative to total), carbohydrates 10–15g, dietary fiber 6–9g. Micronutrients per 100g: magnesium 550–600mg (~140% RDI; among highest plant sources), zinc 7–10mg (~70–90% RDI; bioavailability moderate due to phytic acid), iron 8–15mg (non-heme; absorption enhanced by co-consumed vitamin C), phosphorus 1100–1200mg, potassium 800–900mg, copper 1.4mg, manganese 4–5mg, selenium 5–9µg. Vitamins: vitamin E (tocopherols) 2–3mg as alpha-tocopherol plus significant gamma-tocopherol ~35mg/100g in cold-pressed seed oil; niacin (B3) 4–5mg; folate ~60µg; thiamine 0.2mg; riboflavin 0.15mg. Bioactive compounds: cucurbitin (a unique cyclic amino acid, ~0.5–2% of seed weight) implicated in prostate and antiparasitic activity; phytosterols 200–400mg/100g (predominantly beta-sitosterol ~100–200mg, delta-7-sterols characteristic of Cucurbita including delta-7-avenasterol and spinasterol, which are unique to this species and poorly absorbed systemically but active in the urogenital tract); lignans (secoisolariciresinol, lariciresinol) with phytoestrogenic activity; carotenoids including lutein and beta-carotene at low concentrations (~0.1–0.5mg/100g); chlorophyll derivatives contributing green coloration of Styrian variety. Phytic acid 4–7g/100g reduces mineral bioavailability by 20–50%; soaking or roasting partially degrades phytates. Cold-pressed Styrian pumpkin seed oil retains the highest concentration of delta-7-phytosterols and tocopherols; roasting increases Maillard-derived flavor compounds but modestly reduces heat-sensitive nutrients. Caloric density approximately 550–570 kcal/100g.
Preparation & Dosage
Clinically studied dose: 65g whole seeds for acute glycemic control. For benign prostatic hyperplasia, pumpkin seed oil was used but exact dosage unspecified. No standardized extract dosing established in human trials. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
Saw palmetto, zinc, selenium, lycopene, beta-sitosterol
Safety & Interactions
Styria pumpkin seeds are generally well-tolerated with mild gastrointestinal upset reported in some individuals at high doses. They may enhance the effects of diabetes medications, requiring blood glucose monitoring and potential dose adjustments. No significant drug interactions have been reported, though the high fiber content may affect absorption of certain medications if taken simultaneously. Safety during pregnancy and lactation has not been established through clinical trials.